Dietmar W. Siemann Awarded National Cancer Institute Grant

EZ_20140917_UF_Siemann_Lab_Staff_0168Dr. Dietmar W. Siemann, a radiobiologist with the Department of Radiation Oncology, was awarded a $1.7 million grant by the National Cancer Institute of the National Institutes of Health for his project titled, “Hypoxia: Impact on Src Signaling and Prostate Cancer.”

Hypoxia is a common feature of most solid tumors, including prostate cancer. It has long been associated with enhanced metastasis and poor patient outcome. Since cancer metastasis has been linked both clinically and experimentally to hypoxia, Dr. Siemann hopes to gain a better understanding of how the varying oxygen deprivations that can occur in solid tumors impact metastasis-associated signaling and behavior. The result should ultimately lead to the development of novel treatment approaches in future cancer patients.

Nationally ranked

U.S. News and World Report

Nationally ranked in 6 adult specialties and 6 pediatric specialties and rated high performing in 4 adult specialties and 5 procedures and conditions.

Award

defining optimal treatments

Annual Research Seminar

The seminar has three concurrent programs for radiation therapy, oncology nursing, and radiation oncology.

Seminar

EXPLORE THE

UF Health Cancer Center

Our Mission is to prevent, detect, treat and ultimately cure cancer while addressing the unique challenges of the cancer burden faced by the population we serve.

UF Health Cancer Center